ATRC
Price
$29.24
Change
-$0.02 (-0.07%)
Updated
Jul 21 closing price
Capitalization
1.45B
7 days until earnings call
CERS
Price
$1.38
Change
+$0.02 (+1.47%)
Updated
Jul 21 closing price
Capitalization
342.62M
9 days until earnings call
Interact to see
Advertisement

ATRC vs CERS

Header iconATRC vs CERS Comparison
Open Charts ATRC vs CERSBanner chart's image
AtriCure
Price$29.24
Change-$0.02 (-0.07%)
Volume$445.12K
Capitalization1.45B
Cerus
Price$1.38
Change+$0.02 (+1.47%)
Volume$892.27K
Capitalization342.62M
ATRC vs CERS Comparison Chart in %
Loading...
ATRC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
CERS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ATRC vs. CERS commentary
Jul 22, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ATRC is a Buy and CERS is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 22, 2025
Stock price -- (ATRC: $29.24 vs. CERS: $1.38)
Brand notoriety: ATRC and CERS are both not notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: ATRC: 102% vs. CERS: 77%
Market capitalization -- ATRC: $1.45B vs. CERS: $342.62M
ATRC [@Medical Specialties] is valued at $1.45B. CERS’s [@Medical Specialties] market capitalization is $342.62M. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $8.74B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ATRC’s FA Score shows that 0 FA rating(s) are green whileCERS’s FA Score has 0 green FA rating(s).

  • ATRC’s FA Score: 0 green, 5 red.
  • CERS’s FA Score: 0 green, 5 red.
According to our system of comparison, CERS is a better buy in the long-term than ATRC.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ATRC’s TA Score shows that 4 TA indicator(s) are bullish while CERS’s TA Score has 4 bullish TA indicator(s).

  • ATRC’s TA Score: 4 bullish, 5 bearish.
  • CERS’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, CERS is a better buy in the short-term than ATRC.

Price Growth

ATRC (@Medical Specialties) experienced а -6.58% price change this week, while CERS (@Medical Specialties) price change was -4.83% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was +2.64%. For the same industry, the average monthly price growth was +4.12%, and the average quarterly price growth was -1.74%.

Reported Earning Dates

ATRC is expected to report earnings on Jul 29, 2025.

CERS is expected to report earnings on Jul 31, 2025.

Industries' Descriptions

@Medical Specialties (+2.64% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ATRC($1.45B) has a higher market cap than CERS($343M). ATRC YTD gains are higher at: -4.319 vs. CERS (-10.390). ATRC has higher annual earnings (EBITDA): -8.11M vs. CERS (-26.34M). ATRC has more cash in the bank: 137M vs. CERS (65.9M). ATRC has less debt than CERS: ATRC (74.5M) vs CERS (96M). ATRC has higher revenues than CERS: ATRC (399M) vs CERS (156M).
ATRCCERSATRC / CERS
Capitalization1.45B343M422%
EBITDA-8.11M-26.34M31%
Gain YTD-4.319-10.39042%
P/E Ratio36.76N/A-
Revenue399M156M256%
Total Cash137M65.9M208%
Total Debt74.5M96M78%
FUNDAMENTALS RATINGS
ATRC vs CERS: Fundamental Ratings
ATRC
CERS
OUTLOOK RATING
1..100
5225
VALUATION
overvalued / fair valued / undervalued
1..100
69
Overvalued
43
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9397
PRICE GROWTH RATING
1..100
9696
P/E GROWTH RATING
1..100
97100
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

CERS's Valuation (43) in the Medical Specialties industry is in the same range as ATRC (69). This means that CERS’s stock grew similarly to ATRC’s over the last 12 months.

CERS's Profit vs Risk Rating (100) in the Medical Specialties industry is in the same range as ATRC (100). This means that CERS’s stock grew similarly to ATRC’s over the last 12 months.

ATRC's SMR Rating (93) in the Medical Specialties industry is in the same range as CERS (97). This means that ATRC’s stock grew similarly to CERS’s over the last 12 months.

ATRC's Price Growth Rating (96) in the Medical Specialties industry is in the same range as CERS (96). This means that ATRC’s stock grew similarly to CERS’s over the last 12 months.

ATRC's P/E Growth Rating (97) in the Medical Specialties industry is in the same range as CERS (100). This means that ATRC’s stock grew similarly to CERS’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ATRCCERS
RSI
ODDS (%)
Bullish Trend 1 day ago
78%
N/A
Stochastic
ODDS (%)
Bullish Trend 1 day ago
78%
Bullish Trend 1 day ago
71%
Momentum
ODDS (%)
Bearish Trend 1 day ago
82%
Bearish Trend 1 day ago
90%
MACD
ODDS (%)
N/A
Bearish Trend 1 day ago
87%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
83%
Bearish Trend 1 day ago
85%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
78%
Bullish Trend 1 day ago
75%
Advances
ODDS (%)
Bullish Trend 13 days ago
72%
Bullish Trend 13 days ago
76%
Declines
ODDS (%)
Bearish Trend 1 day ago
84%
Bearish Trend 5 days ago
84%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
83%
Bearish Trend 1 day ago
87%
Aroon
ODDS (%)
Bearish Trend 1 day ago
83%
Bullish Trend 1 day ago
75%
View a ticker or compare two or three
Interact to see
Advertisement
ATRC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
CERS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
RUBLF1.470.03
+2.08%
Rubellite Energy Corp.
HTHIF29.600.05
+0.17%
Hitachi Ltd.
STKAF3.55N/A
N/A
Stockland
RVTI0.02N/A
N/A
Rival Technologies, Inc.
PIAGF2.25-0.04
-1.95%
Piaggio & C Spa Pontedera

ATRC and

Correlation & Price change

A.I.dvisor indicates that over the last year, ATRC has been loosely correlated with SIBN. These tickers have moved in lockstep 45% of the time. This A.I.-generated data suggests there is some statistical probability that if ATRC jumps, then SIBN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ATRC
1D Price
Change %
ATRC100%
-0.07%
SIBN - ATRC
45%
Loosely correlated
+0.30%
CERS - ATRC
43%
Loosely correlated
+1.47%
IRMD - ATRC
43%
Loosely correlated
-0.88%
NVST - ATRC
40%
Loosely correlated
-0.21%
KIDS - ATRC
39%
Loosely correlated
-0.59%
More

CERS and

Correlation & Price change

A.I.dvisor indicates that over the last year, CERS has been loosely correlated with LAB. These tickers have moved in lockstep 53% of the time. This A.I.-generated data suggests there is some statistical probability that if CERS jumps, then LAB could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CERS
1D Price
Change %
CERS100%
+1.47%
LAB - CERS
53%
Loosely correlated
+2.44%
DHR - CERS
47%
Loosely correlated
-1.04%
BLFS - CERS
47%
Loosely correlated
-0.34%
UTMD - CERS
46%
Loosely correlated
+0.05%
NNOX - CERS
46%
Loosely correlated
+0.58%
More